Transcript Highlights:

• </c> entities of concern from influencing entities of concern from influencing litigation<01:05:57.440
• </c> offset the prescription drug offset the prescription drug affordability<03:18:40.800><c> board</
• </c> They're supposed to lower drug costs. They're supposed to lower drug costs.
• </c> They have no real control over drug They have no real control over drug costs.<03:21:47.439><c>
• Good RX, uh cost plus drugs, there.

Summary: The committee first considered House Bill 66, a right-to-know measure that would broaden access from “citizen” to “person,” including out-of-state requesters. Members also adopted an amendment removing the current no-filing-fee provision for appeals of unfavorable right-to-know ombudsman rulings, citing budget concerns. The bill was then reported ought to pass as amended on a 16-9 vote, with a minority report requested. House Bill 187, which would let a parent or guardian seek a protective order on behalf of a minor alleging abuse by someone outside the family or household, was described as a narrow fix with little fiscal impact. It passed unanimously, 25-0, and was placed on the consent calendar. House Bill 215, requiring landfill permit applicants to submit a report on potential harms and benefits, was retained because its policy had been folded into House Bill 2; the committee voted 25-0 to retain it. House Bill 219, dealing with renewable portfolio standard changes and lower renewable energy certificate values, drew opposition from members who said it would weaken renewable energy development and raise concerns about energy costs, but the motion to retain was adopted 14-11, allowing the bill to be moved into House Bill 2. The committee then retained House Bills 365, 552, 566, 572, 607, 611, and 624, all by unanimous or near-unanimous votes, generally because the relevant policy or funding had been incorporated into House Bill 2 or because the bills were viewed as technical or low-impact. HB 566 was described as a landfill leach-management bill with a fiscal note under $10,000 annually and was sent to consent. HB 572 and HB 607 were retained because their money components were moved into HB 2, though one member objected that HB 607 represented an unfunded mandate for the Hampton Beach Area Commission. House Bill 511, concerning ICE detainers and county detention practices, generated the most debate. Supporters said the amendment clarified how long counties may hold detainees without a federal contract and compared the detention period to existing bail rules; opponents argued the bill could sanction detention of people not charged with crimes and raised due-process concerns. The committee adopted the amendment 14-11 and then reported the bill ought to pass as amended on another 14-11 vote, with a minority report requested. House Bill 639, involving securities and digital currency issues, was also reported ought to pass after members noted unresolved concerns but said the Secretary of State’s Securities Division was willing to continue working on it in the other body; the vote was 16-10.

Transcript Highlights:

• </c> drugs in the community. drugs in the community.
• drugs is illegal<01:17:20.760><c> everywhere.
• drug crime.
• By implementing measures to deter drug By implementing measures to deter drug use<01:20:44.400><c> in
• </c><01:22:27.360><c> zones</c> despite evidence that drug-free zones despite evidence that drug-free

Bills: SB709 , SB2089 , SB2090 , SB2108 , SB2211 , SB2250 , SB2325 , SB2803 , SB2866 , SB3245

Committee: House Human Services & Homelessness

Summary: The committee heard SB 709 SD2, which would require the Department of Health to respond to reports involving persons with severe mental illness, assess eligibility for assisted community treatment, and coordinate treatment when appropriate. Testimony from the Department of Human Services and the Department of Health supported the measure, with DOH saying it generally supported the bill but had comments on one section it viewed as unnecessary. The Department of Law Enforcement later explained that the bill would shift certification and standards for crisis intervention officer training from DOH to DLE, while still involving DOH in the training process. Opposition came from the Hawaii Disability Rights Center and an individual testifier, both of whom argued the bill expands state authority over people with mental illness and could worsen forced treatment practices. The Disability Rights Center also raised procedural concerns, saying the bill was effectively moved from a prior administration measure that had not been heard this session, and questioned whether the bill’s changes to assisted community treatment, blood tests, urinalysis, and living arrangements went beyond current law. The individual testifier argued the bill would further entrench harmful psychiatric drugging and urged the committee to defer it. Committee members questioned the administration about the bill’s process, the role of the Attorney General in treatment-over-objection proceedings, and the practical effects of moving CIT certification to DLE. The Attorney General’s office said the bill was intended to fill a gap by allowing it to assist with treatment proceedings, while public defenders would continue to represent respondents and due process protections would remain in place. DLE and DOH said the change would better align certification with law enforcement training needs, improve speed in crisis response, and still keep DOH involved; members also discussed whether WAM counted as a hearing and whether the bill should more explicitly preserve DOH’s role. No vote or final action was taken in the portion provided.

Transcript Highlights:

• </c> know I was drugged." know I was drugged."
• </c> convicted on five felony charges of drug convicted on five felony charges of drug trafficking.<03
• ><c> the</c> Whether undue influence over the Whether undue influence over the attorney<03:45:30.960>
• To show that she'd been drugged, but nope, wouldn't do it.
• </c> references potential undue influence references potential undue influence over<05:13:36.798><c>

Committee: House Executive Departments and Administration

Transcript Highlights:

• brand-name drug.
• brand-name drug.
• I said, well, it's ...generic drug as a brand-name drug. I said, well, it's generic.
• And they said, well, your drug is now called a generic drug with a brand name that is generic drug.
• Drugs like Advil and Tylenol didn't cut it.

Committee: Joint Joint Committee on Health Care Financing

Summary: The Joint Committee on Health Care Financing held a public hearing on 16 bills, with the chairs noting a busy legislative day and asking speakers to keep testimony brief. The committee first heard testimony on Senate 860/House 1405, the Medicare for All bill, with Sen. Jamie Eldridge and many advocates, clinicians, municipal officials, and patients arguing that a single-payer system would make care a right, reduce administrative waste, lower costs, and protect residents from rising premiums, medical debt, and hospital closures. Several speakers cited the Steward hospital crisis, affordability problems, and polling or ballot questions showing public support for single-payer coverage. No vote was taken during the hearing. The committee then took testimony on S. 863, a bill on non-opioid options for chronic pain. Pain specialists, patients, and advocates said the bill would improve care coordination for MassHealth members, expand access to non-opioid medications, require provider education, and collect data on chronic pain. Testifiers described long delays in diagnosis and treatment, stigma toward pain patients, and the need for multidisciplinary care and transportation support. Again, the committee heard testimony only and took no action. A large portion of the hearing focused on H. 1360/S. 869, which would prevent discrimination against people with disabilities in health care. Disability advocates, clinicians, and patients described being denied or delayed care, pressured into DNR orders, or treated based on assumptions about quality of life rather than medical facts. Speakers referenced COVID-era crisis standards of care, discriminatory metrics, and personal stories involving canceled procedures, inadequate accommodations, and poor treatment in hospitals. Committee members thanked speakers for their testimony and said they would review the bill and its implications, but no vote was announced. The committee also heard testimony on H. 1399, an individual Medicare marketplace option for municipal retirees, where supporters said it would give cities and towns a lower-cost alternative for retiree health benefits through HRAs and individual Medicare plans. The hearing then returned to Medicare for All testimony, with additional supporters repeating arguments about cost, access, municipal budget pressure, and the need for global budgeting and universal coverage. The transcript ends with continued testimony and no recorded committee vote or final action on any bill.

Transcript Highlights:

• If a hospital can buy that drug at a 340B discount, say $100,000, and then resell the drug to Medicare
• on the expenses of these drugs.
• value for these high-cost drugs.
• for these high-cost drugs.
• Specialty drugs account for roughly 2% of drugs.

Committee: Joint Joint Committee on Financial Services

Summary: The committee held a lengthy hearing on a large docket of pharmacy and drug-pricing bills, with most testimony focused on PBM reform, 340B drug discount program protections, specialty medication access, and medication adherence. Chair James Murphy and Senator Paul Feeney opened the hearing and took testimony from legislators, patient advocates, pharmacists, health center leaders, industry representatives, and policy groups. Several speakers described delays, denials, high out-of-pocket costs, and pharmacy closures tied to PBM practices, while others emphasized the importance of community health centers and independent pharmacies in serving patients. On the 340B program, supporters including Senator Eldridge, Senator Payano, Community Care Cooperative, Fenway Health, the Massachusetts League of Community Health Centers, and several community health center leaders argued that bills such as H. 1107 and S. 819 would stop discriminatory PBM and manufacturer practices, preserve contract pharmacy access, and protect safety-net providers that say they reinvest savings into care, pharmacy expansion, interpreter services, behavioral health, and other services. Opponents including PhRMA, the Community Liver Alliance, and a public policy analyst argued the program lacks transparency and accountability, has grown beyond its original purpose, and may benefit large hospitals and for-profit entities more than low-income patients. They urged more reporting and oversight rather than expanding protections. On PBM reform, testimony supported bills including H. 1157, H. 1234, S. 724, S. 831, and related measures that would require rebate pass-through, ban spread pricing, limit steering to PBM-owned pharmacies, and improve reimbursement for community pharmacies. Independent pharmacists and patients said current PBM practices raise costs, create administrative burdens, and threaten access to local pharmacies. PCMA, representing PBMs, opposed the reforms, arguing PBMs lower costs, that plan sponsors choose to contract with them, and that the Health Policy Commission and CHIA should complete their ongoing study before new mandates are adopted. The committee also heard support for H. 1322 and S. 734 on specialty medications, and for H. 781 and H. 1305 on medication synchronization to improve adherence. No votes or formal actions were taken during the hearing.

Transcript Highlights:

• </c> are at the peak of impact and influence are at the peak of impact and influence and<00:20:22.400
• The Inflation Reduction Act changed the maximum out-of-pocket for prescription drugs from $8,000 per
• The Inflation Reduction Act changed the maximum out-of-pocket for prescription drugs from $8,000 per
• The Inflation Reduction Act changed the maximum out-of-pocket for prescription drugs from $8,000 per
• The Inflation Reduction Act changed the maximum out-of-pocket for prescription drugs from $8,000 per

Summary: The meeting opened with roll call, a quorum was confirmed, and the minutes were approved. The committee then heard testimony on Senate Bill 9, which concerns TRS sick leave audit requirements and process. Auditor Allison Ball’s staff said the audit is an information-gathering review of how teacher sick leave is accumulated, current balances, how many employers use the sick leave function, and the policies and procedures governing sick leave. Members discussed how unused sick leave affects retirement calculations, the distinction between the state’s financial responsibility and school districts’ responsibility, and whether the audit would also examine related leave categories such as personal leave, annual leave, and leave of absence. Committee members emphasized that Senate Bill 9 was intended to add accountability and standardize reporting, including preventing annual leave from being rolled into sick leave. Several members asked for clarification on how sick leave is factored into retirement benefits. Witnesses and members explained that, under the system described, accumulated sick leave can be converted into retirement credit based on a teacher’s daily rate and then multiplied by a percentage, with the school district often bearing the cost. Members also noted nuances in the law, including different accumulation limits by hire date and tier, and that the audit may help the public better understand why some educators retire relatively young. The auditor’s office said it is still early in the process, has met with TRS leadership, and will report back once the audit progresses. The committee also asked whether maternity leave would be included; the auditor’s office said it was not specifically mandated but could be examined if the body requests it. The committee then received an overview of Senate Bill 10 from KPA representatives Ryan Barrow and Rebecca Atkins. They explained that the bill enhances retiree health insurance benefits for certain CRS members who are non-Medicare participants and meet specified career thresholds, with different rules for hazardous and non-hazardous service. They described the benefit as $40 per month per year of service for non-hazardous service and $50 per month per year for hazardous service, both inflated annually, and clarified that these amounts are not cumulative with prior benefit formulas. Members asked about the interaction between the new amounts and existing benefits, and the presenters explained that the bill also changes current employee health insurance contribution rates effective July 1, 2026, with different impacts by tier and hazardous status. The committee discussed the need for clear communication to affected employees and reviewed example calculations showing how the new contribution structure would work.

Transcript Highlights:

• There's a program for that, the drug offender sentencing alternative.
• the manufacture, delivery, or sale of controlled substances, and felony-level driving under the influence
• A defendant may... ...and, again, felony driving under the influence or physical control.
• And drug offenses are made eligible. Right. Okay. Terrific. Well, thanks.
• In this jurisdiction, deferred adjudication is a common option for first-time property and drug felony

Summary: The House Community Safety Committee met on January 29, 2026, and announced it would not hold executive session that day because of the large number of public hearing sign-ups; those executive sessions were pushed to the following Monday. The committee first heard House Bill 2558, relating to the mental health sentencing alternative (MHSA). Staff explained that the bill narrows eligibility to people diagnosed with a psychotic disorder, adds restrictions for certain domestic violence and prior violent offense cases, requires more detailed DOC reports, lengthens some community custody terms, mandates regular progress hearings, and shifts assessment work to contracted providers. The sponsor said the bill is intended to refocus the program on people whose offenses are tied to serious mental illness and to reduce misuse in domestic violence and other violent cases. No public testimony was taken on HB 2558 that day, and the hearing was held open for later testimony. The committee then heard House Bill 2217, which would replace the current first-time offender waiver with a pretrial deferral option and a suspended sentence option for eligible first-time felony defendants. Supporters, including public defense, immigration advocates, judges, economists, and the Sentencing Guidelines Commission, argued the bill would create a meaningful rehabilitation pathway, reduce recidivism, improve employment outcomes, and avoid the long-term harm of an immediate felony conviction. They also said the deferred-adjudication structure could help immigrants avoid immigration consequences and would better incentivize restitution and compliance. Opponents, including sheriffs, prosecutors, and victim advocates, raised concerns about expanding eligibility to offenses such as assault 2 and robbery 2, the meaning of “violent offense,” the possibility of judicial diversion without prosecutor consent, and the impact on victims and public safety. After testimony, the sponsor said she would remove the bill’s strong presumption in favor of relief, and the committee closed the public hearing on HB 2217. Finally, the committee heard House Bill 2641, the “ICE Out Act of 2026,” which would bar Washington law enforcement agencies from hiring people who were sworn ICE officers after January 20, 2025, with the restriction applying prospectively beginning October 1, 2026. The sponsor said the bill was meant to protect communities and prevent hiring officers associated with federal immigration enforcement practices she described as harmful. The committee then heard House Bill 2648, which would require state and local officers who encounter suspected ICE employees conducting immigration enforcement to activate body and dash cameras, report the encounter, and document it, while providing state indemnification for officers acting in good faith. Supporters said the bill would improve transparency and protect communities and officers; the Washington State Patrol said many of the practices already align with its policies. The Washington Association of Sheriffs and Police Chiefs expressed concerns about added reporting requirements, possible effects on federal-local cooperation, and asked for changes to soften mandatory language and strengthen indemnification. The committee ended the hearing without further testimony and adjourned, noting executive sessions on about a dozen bills would occur the following week.

Transcript Highlights:

• What do they do currently and what additional drugs would they be able to administer with your bill?
• It's a prescribed drug and you're not allowed to prescribe.
• It just allows them to acquire these drugs. Representative Birch. Thank you, Mr. Chairman.
• It says to prescribe certain prescription drug products. Representative Crane: Thank you, Mr.
• Why, I thought pharmacists just dispense drugs.

Committee: House Business

Transcript Highlights:

• We're not going to have any control or influence over that. I've heard that one before.
• The driver beat his drug test.
• of drugs and over his hours, which ultimately led to him falling asleep at the wheel.
• Drug screen for the company that hired him anyway, and they have zero regulations in place.
• The company never drug tested the driver.

Bills: SB39 , SB2129 , SB2141 , SB2246 , SB2323 , SB2439 , SB2722 , SB 39

Committee: Senate Transportation

Transcript Highlights:

• We also need more public support for drug development and for treatment.
• Drug repurposing, finding new uses for existing medications, this is also fast and cost-effective.
• DoD is looking at the early stage drug development. The FDA is doing clinical trials.
• approved. by the FDA in the last 2010 to 2019, 356 new drugs.
• You see them on television all the time. 356 new drugs. How many came out of NIH?

Committee: Senate Senate Appropriations

Transcript Highlights:

• obviously</c><01:04:36.279><c> um</c><01:04:36.599><c> a</c> the drug drug driving is obviously um a
• the drug drug driving is obviously um a new<01:04:37.240><c> it's</c><01:04:37.599><c> newer</c><01:04
• </c> also the stories um to include drugged also the stories um to include drugged driving<01:04:57.359
• </c> and yet this is a highly Airborne drug and yet this is a highly Airborne drug that<05:33:52.000>
• I drugs.

Committee: House Criminal Justice and Public Safety

Transcript Highlights:

• Kratom is not federally regulated as a controlled substance, nor has the Federal Food and Drug Administration
• prime sponsor said she was not sure they had contemplated the driving element or driving under the influence
• I also want to say, as a community store owner, I did not need to sell mind-altering drugs to make a
• I also want to say, as a community store owner, I did not need to sell mind-altering drugs to make a
• And I wonder if RCW 46.61.502 that just says under the influence of any drug would be adequate without

Summary: The Consumer Protection and Business Committee held a public hearing on House Bill 2291, the Kratom Consumer Protection Act, and then moved into executive session on several bills. Staff explained that HB 2291 would license kratom retailers and processors, set age 21 purchase limits, require labeling, child-resistant packaging, independent testing, an LCB-approved product directory, and an 11% excise tax, while banning certain synthetic or adulterated kratom products and restricting online/mail sales and public consumption. The prime sponsor said the bill was intended to regulate natural kratom while banning the synthetic or chemically altered forms, and several witnesses supported stronger youth protections and product standards. Others opposed the bill’s licensing fee, statewide preemption of local bans, or the regulatory approach, while some testified that natural kratom helps with pain or recovery. The hearing on HB 2291 was then closed without action. In executive session, the committee took action on multiple bills. HB 2439, dealing with cigarette, vapor product, and tobacco product policy, was amended and reported out with a do pass recommendation; the adopted amendments limited Consumer Protection Act enforcement to the Attorney General, adjusted coupon language, and restored state preemption over local retail regulation. HB 1078 on pet insurance, HB 1701 on shared liquor-license premises, HB 2207 on bonded beer warehousing, and HB 2501 on real estate oil-tank disclosure were all reported out with do pass recommendations, with HB 1701’s substitute removing a Public Records Act exemption and HB 2207’s substitute aligning beer warehousing more closely with spirits warehouse rules. HB 2361, which raises the maximum small loan amount, was amended to make inflation adjustments biennial and to change publication requirements, then passed out of committee. The committee also approved HB 1932, which would authorize cannabis consumption events in regulated environments. The substitute bill would create a cannabis consumption event organizer license, allow limited adult-use events subject to local approval, and establish permit and budtender training requirements; members discussed the bill as a way to provide lawful consumption spaces while others objected to expanding cannabis access. In the final votes, HB 2439 passed 12-3, HB 1078 passed unanimously, HB 1701 passed 14-1, HB 2207 passed 14-1, HB 2501 passed unanimously, HB 2361 passed 13-2, and HB 1932 passed 11-4, all with do pass recommendations.

Transcript Highlights:

• Section 15 of Article 7 modifies the timing of when a pharmacy may apply for a refund of the legend drugs
• paid to a wholesale drug distributor for drugs that the pharmacy then delivers outside of the state.
• Large majorities across party lines say that big campaign donors and special interests have too much influence
• Own districts, by contrast, are widely viewed as having too little influence.
• Thanks for including the baby bonus tax and the drug tax stamp, Chairs. I really appreciate that.

Bills: HF2730 , HF2257 , HF2768 , HF1932 , HF2437

Committee: House Taxes

Transcript Highlights:

• What if she's trafficking the drugs for herself? Thank you for the question.
• How is this particular drug different from any other illegal drug?
• Or, that a lot of these drugs that are not making it into our state. Follow up.
• And what helped them was not eliminating a drug. What helped them...
• And at the end of the day, these drugs don't give choice.

Bills: HB1168

Transcript Highlights:

• It prohibits tampering or harassment of court officials with the intent to influence or retaliate against
• Was there a particular case incident that influenced this legislation? You're recognized, Senator.
• As I was seeing as a drug on the streets, it is illegal for human consumption.
• This bill addresses a drug that is being circulated on the streets.
• The drugs are being circulated on the streets and are being mixed with marijuana and other substances

Transcript Highlights:

• And other technology improvements that could benefit CBP's ability to interdict drugs.
• Yes or no, are the vast majority of drug seizures, including fentanyl, made at legal point?
• The FBI recently put out a memo pertaining to Chinese Communist Party and their influence along. the
• an issue to say if you're a current drug user or past drug user on that At least to be able to get that
• but it's unmanned aerial vehicles coming across the border at 5,000 feet and just dropping the drugs

Committee: Senate Finance Committee

Keywords: Customs and Border Protection, Rodney Scott, border security, asylum, transparency, Hernandez Rojas, migrant treatment, public testimony

Summary: The meeting centered on the nomination of Rodney Scott to serve as the Commissioner of U.S. Customs and Border Protection (CBP). Throughout the session, various senators expressed concerns regarding CBP's recent practices, including issues related to border security and the treatment of migrants. Questions were raised about Scott's involvement in previous incidents, particularly surrounding the controversial death of Mr. Hernandez Rojas while in custody, which sparked a heated discussion about accountability and transparency in current border policies. Senators emphasized the importance of balancing efficient border security with humane treatment of individuals seeking asylum.

Transcript Highlights:

• You'll note that there's a thing on U of M drug trial monitoring.
• Some years ago there was a controversy over informed consent in some drug trials involving juveniles,
• trial monitoring some years ago ofm drug trial monitoring some years ago there<00:25:49.279><c> was<
• consent uh in some drug trials involving juveniles<00:25:55.320><c> and</c><00:25:55.520><c> the</c>
• </c><00:26:04.520><c> trials</c> un University of Minnesota drug trials un University of Minnesota drug

Committee: House Human Services Finance and Policy

Transcript Highlights:

• Cole National Historic Site in Catskill, where he served for 20 years, serving the richness and influence
• FOOD AND DRUG ADMINISTRATION 70H, BY THE WAY, I WANT TO TELL YOU, IT IS 7 HYDROXY MITRAGYNINE.
• Food and Drug Administration 7-OH, by the way, I want to tell you, it is 7-hydroxymitragynine.
• Are we driving people to deadlier drugs potentially?
• of alcohol or drugs, taking away those licenses, preventing them from driving, keeping them off the

Summary: The Senate convened, approved the prior day’s journal, and then processed a large number of motions to discharge bills from committees and substitute identical Senate or Assembly versions for third reading. The chamber also adopted the resolution calendar with exceptions and took up several resolutions and ceremonial recognitions, including a resolution mourning Hudson Talbott, a Dairy Month resolution highlighting New York’s dairy industry, and introductions honoring Niskayuna academic teams, Gabriella Scheer for receiving the Liberty Medal, the Hartstein family’s civic engagement, and Diana Cochran’s advocacy for safe firearm storage. The Senate then moved through the calendar and passed many bills on topics including insurance, public health, education, labor, social services, banking, local government, veterans, public service, consumer protection, criminal procedure, cannabis, parks, taxation, election law, and highway matters. Several members explained votes on notable measures: support for acupuncture insurance coverage, consumer protections for doorbell-camera data sharing, expanded protections in debt collection cases, trauma-informed procedures for sexual assault survivors, a Legionnaires’ disease awareness program, changes to mandatory minimum sentencing, and universal safe storage of firearms. A number of home rule and local authorization bills were also approved, including parkland alienation measures and local tax exemption authorizations. Most measures passed with broad bipartisan support, though some drew recorded opposition. Notable roll calls included the consumer debt uniformity bill, the mandatory minimum sentencing bill, the safe storage/firearms bill, and the public housing and public health measures, each with more divided votes. The chamber also accepted a lengthy Rules Committee report sending many additional bills directly to third reading, and then began the supplemental calendar, passing at least the first items before the transcript ended.

Transcript Highlights:

• drugs, it sounds like, but there's some drugs that could be harmful or a problem.
• They're under the care of a pill mill that is just trying to sell drugs.
• It wasn't led by science; it was political pressure, big pharma influence.
• A lot of these drugs require very specific monitoring to ensure safety, including EKGs and drug concentration
• You know, we do prescribe these drugs. They are doctors. They are licensed.

Summary: The committee first approved the January 28, 2026 minutes and held Senate Bill 1241 for a later hearing because a witness was unavailable. It then took up Senate Bill 1144, which would create an alternative pathway for veterinary technician certification through supervised on-the-job training and board-approved skills standards. Supporters, including the Arizona Humane Society, a high school student in a veterinary program, and other advocates, said the bill would help address workforce shortages, reduce student debt, and improve access to care, especially in rural and low-income areas. Opponents, including the Arizona Veterinary Technician Association and several veterinarians, argued the bill could weaken training standards, increase liability, and create safety risks; the Arizona Veterinary Medical Association ultimately moved to neutral after amendments added supervision and affidavit requirements. The committee adopted the amendment and then passed SB 1144 as amended on a 6-1 vote. The committee next passed Senate Bill 1247 unanimously. That bill would allow a person who does not receive care services to live with a resident in an assisted living center, and would bar the Department of Health Services from imposing requirements on that person that the resident would not face. Supporters said the bill was needed to fix a recent agency interpretation that could force spouses or other companions to separate or pay for services they do not use, and noted a possible floor amendment to extend the same treatment to assisted living homes. The committee then heard Senate Bill 1286, which would extend from 14 days to 60 days the period for veterinary prescriptions and renewals issued through telemedicine. Supporters said the change would improve access in underserved and rural areas and reflect how telemedicine is already used in human medicine, while opponents warned that longer telemedicine prescriptions could delay necessary exams and diagnostics, increase the risk of misdiagnosis, and create animal welfare and liability concerns. After testimony, the sponsor asked that the bill be held for a possible amendment next week, so no vote was taken. The committee also passed Senate Bill 1164, which would allow Medicaid claims to continue under a prior owner’s billing number during a skilled nursing or assisted living facility change of ownership until new enrollment is complete; supporters said this would prevent long reimbursement delays, while Access raised concerns about federal-law conflicts and said it needed advance notice to process ownership changes. The bill passed 6-0 with one member not voting. Finally, the committee passed Senate Bill 1181, which expands CPA licensure pathways by allowing combinations of degree and work experience and updates reciprocity and rulemaking provisions, and Senate Bill 1415, which creates a licensing path for salaried insurance adjusters with out-of-state credentials, subject to an amendment clarifying exam and employment requirements. Both bills were supported as workforce and mobility measures, and both were reported out of committee on unanimous or near-unanimous votes.

Transcript Highlights:

• an increase in FDA approval of new drugs.
• The first is weight loss drugs.
• :44.440><c> in</c> care also covers weight loss drugs in care also covers weight loss drugs in the<00
• </c> expenditures uh for weight loss drugs expenditures uh for weight loss drugs covered<00:19:51.559
• </c> communities including intravenous drug communities including intravenous drug users<00:56:20.640

Committee: Senate Health and Human Services